Abivax S.A. (ABVX)
NASDAQ·Healthcare·Biotechnology
$119.58
-4.14%
Mkt Cap $7.19B
Analyst Ratings
Buy
6
Hold
2
Sell
0
Price Target (22 analysts)
$123.43
Range $90.00 – $150.00
Implied Upside
+3.2%
Consensus $123.43 vs current $119.58
NASDAQ·Healthcare·Biotechnology
$119.58
-4.14%
Mkt Cap $7.19B
Buy
6
Hold
2
Sell
0
Price Target (22 analysts)
$123.43
Range $90.00 – $150.00
+3.2%
Consensus $123.43 vs current $119.58